Sinor AD et al. |
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. |
2000 |
Neurosci. Lett. |
pmid:10653017
|
Yan MS et al. |
[Cannabinoids, cannabinoid receptor and immune response]. |
2000 |
Sheng Li Ke Xue Jin Zhan |
pmid:12545719
|
Melck D et al. |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. |
2000 |
Endocrinology |
pmid:10614630
|
Sugiura T et al. |
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. |
2000 |
J. Biol. Chem. |
pmid:10617657
|
Zygmunt PM et al. |
Anandamide - the other side of the coin. |
2000 |
Trends Pharmacol. Sci. |
pmid:10664604
|
Jarrahian A et al. |
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. |
2000 |
J. Neurochem. |
pmid:10820223
|
Davis JB et al. |
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. |
2000 |
Nature |
pmid:10821274
|
Zygmunt PM et al. |
The anandamide transport inhibitor AM404 activates vanilloid receptors. |
2000 |
Eur. J. Pharmacol. |
pmid:10822052
|
Maccarrone M et al. |
Anandamide uptake by human endothelial cells and its regulation by nitric oxide. |
2000 |
J. Biol. Chem. |
pmid:10788462
|
Yagen B and Burstein S |
Novel and sensitive method for the detection of anandamide by the use of its dansyl derivative. |
2000 |
J. Chromatogr. B Biomed. Sci. Appl. |
pmid:10798298
|
Costa B et al. |
Precipitated and spontaneous withdrawal in rats tolerant to anandamide. |
2000 |
Psychopharmacology (Berl.) |
pmid:10805606
|
Braud S et al. |
Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid. |
2000 |
FEBS Lett. |
pmid:10760504
|
Hao S et al. |
Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. |
2000 |
Eur. J. Pharmacol. |
pmid:10762668
|
Lockwood CJ |
Prediction of pregnancy loss. |
2000 |
Lancet |
pmid:10776739
|
Beltramo M and Piomelli D |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. |
2000 |
Neuroreport |
pmid:10817598
|
Zygmunt PM et al. |
Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10832608
|
Gómez del Pulgar T et al. |
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. |
2000 |
Biochem. J. |
pmid:10749665
|
Fernandez-Patron C et al. |
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. |
2000 |
Circ. Res. |
pmid:11029402
|
Maccarrone M et al. |
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11095952
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Valk P et al. |
Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2. |
2000 |
Hematol. J. |
pmid:11920199
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Rubino T et al. |
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. |
2000 |
J. Neurochem. |
pmid:11080200
|
Giuffrida A et al. |
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. |
2000 |
Eur. J. Pharmacol. |
pmid:11080522
|
Stefano GB |
Endocannabinoid immune and vascular signaling. |
2000 |
Acta Pharmacol. Sin. |
pmid:11603279
|
Hansen HH et al. |
Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons. |
2000 |
J. Neurochem. |
pmid:10899965
|
Di Marzo T et al. |
Endocannabinoids: new targets for drug development. |
2000 |
Curr. Pharm. Des. |
pmid:10903398
|
Palmer SL et al. |
Natural and synthetic endocannabinoids and their structure-activity relationships. |
2000 |
Curr. Pharm. Des. |
pmid:10903399
|
Szöke E et al. |
Interacting effects of capsaicin and anandamide on intracellular calcium in sensory neurones. |
2000 |
Neuroreport |
pmid:10884049
|
Szolcsányi J |
Anandamide and the question of its functional role for activation of capsaicin receptors. |
2000 |
Trends Pharmacol. Sci. |
pmid:10838604
|
Piomelli D et al. |
The endocannabinoid system as a target for therapeutic drugs. |
2000 |
Trends Pharmacol. Sci. |
pmid:10838609
|
Fichera M et al. |
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors. |
2000 |
J. Med. Chem. |
pmid:10882356
|
Hohmann AG and Herkenham M |
Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. |
2000 |
Synapse |
pmid:10842353
|
Spicuzza L et al. |
Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves. |
2000 |
Br. J. Pharmacol. |
pmid:10928980
|
Salzet M et al. |
Comparative biology of the endocannabinoid system possible role in the immune response. |
2000 |
Eur. J. Biochem. |
pmid:10931174
|
Hillard CJ |
Endocannabinoids and vascular function. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10871291
|
Song ZH and Zhong M |
CB1 cannabinoid receptor-mediated cell migration. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10871313
|
Tytgat J et al. |
Cannabinoid mimics in chocolate utilized as an argument in court. |
2000 |
Int. J. Legal Med. |
pmid:10876983
|
Andersson M et al. |
Neurotoxicity of glutamate in chick telencephalon neurons: reduction of toxicity by preincubation with carbachol, but not by the endogenous fatty acid amides anandamide and palmitoylethanolamide. |
2000 |
Arch. Toxicol. |
pmid:10877002
|
Maccarrone M et al. |
Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. |
2000 |
Lancet |
pmid:10776746
|
Houser SJ et al. |
Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. |
2000 |
Brain Res. |
pmid:10700588
|
Lay L et al. |
Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. |
2000 |
Eur. J. Pharmacol. |
pmid:10720647
|
Tiger G et al. |
Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate. |
2000 |
Biochem. Pharmacol. |
pmid:10677581
|
Bannerman P et al. |
Early migratory rat neural crest cells express functional gap junctions: evidence that neural crest cell survival requires gap junction function. |
2000 |
J. Neurosci. Res. |
pmid:10972957
|
Palkovits M |
[The brain and the pain: neurotransmitters and neuronal pathways of pain perception and response]. |
2000 |
Orv Hetil |
pmid:11184247
|
Di Marzo V et al. |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. |
2000 |
FASEB J. |
pmid:10877836
|
Maccarrone M and Finazzi-Agró A |
Platelet activation: a new vascular activity of anandamide. |
2000 |
FEBS Lett. |
pmid:11184253
|
Lagalwar S et al. |
Anandamides inhibit binding to the muscarinic acetylcholine receptor. |
1999 Aug-Oct |
J. Mol. Neurosci. |
pmid:10691292
|
Kiss Z |
Anandamide stimulates phospholipase D activity in PC12 cells but not in NIH 3T3 fibroblasts. |
1999 |
FEBS Lett. |
pmid:10214947
|
Sagan S et al. |
Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. |
1999 |
Eur. J. Neurosci. |
pmid:10051770
|